NUTEX HEALTH INC. (NUTX) FY2026 YTD Q2 P&L / Income Statement

NUTEX HEALTH INC. (NUTX) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenue

427,237,000 US dollars

Cost of revenue (calculated)

194,228,000 US dollars

Gross profit

233,009,000 US dollars

Total corporate and other costs

30,026,000 US dollars

Operating income

202,983,000 US dollars

Other income (expense), net (calculated)

negative 9,338,000 US dollars

Income before taxes

193,645,000 US dollars

Income tax expense

34,565,000 US dollars

Net income

159,080,000 US dollars

Hospital division

409,422,000 US dollars

Population health management division

17,815,000 US dollars

Total operating costs and expenses

194,228,000 US dollars

Stock-based compensation

negative 1,031,000 US dollars

General and administrative expenses

31,057,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to NUTEX HEALTH INC.: $112.65 M; to noncontrolling interests: $46.43 M.